Molecular Insight Pharmaceuticals, Inc. (MIPIQ.PK)

HEALTH CARE: HEALTH CARE
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

160 SECOND STREET CAMBRIDGE, MA 02142

View SEC Filings from MIPIQ.PK instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MIPIQ.PK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MIPIQ.PK BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BARLOW DAVID S

  • 10% Owner
2,361,377 2011-01-27 0

ATTARIAN MARK A INTERIM EVP & CFO

  • Officer
0 2010-12-08 0

DONDERO JAMES D

HIGHLAND CAPITAL MANAGEMENT LP

STRAND ADVISORS, INC.

  • SEE FOOTNOTE 1SEE FOOTNOTE 1SEE FOOTNOTE 1
0 2010-06-27 0

QVT ASSOCIATES GP LLC

QVT FUND LP

QUINTESSENCE FUND L.P.

  • REFERENCE REMARKS (2) BELOWREFERENCE REMARKS (2) BELOWREFERENCE REMARKS (2) BELOW
364,581 2010-06-27 0

QVT ASSOCIATES GP LLC

QVT FUND LP

  • REFERENCE REMARKS (2) BELOWREFERENCE REMARKS (2) BELOW
364,581 2010-06-27 0

PIONEER FLOATING RATE TRUST

  • REFERENCE FOOTNOTE 1.
0 2010-06-27 0

MCDONNELL LOAN OPPORTUNITY LTD.

  • SEE REMARKS
0 2010-06-27 0

TACONIC CAPITAL ADVISORS LP

TACONIC ASSOCIATES LLC

TACONIC CAPITAL ADVISORS UK LLP

BRODY KENNETH D

BROSENS FRANK

  • REFERENCE FOOTNOTE 1REFERENCE FOOTNOTE 1REFERENCE FOOTNOTE 1REFERENCE FOOTNOTE 1REFERENCE FOOTNOTE 1
0 2010-06-27 0

STYLLI HARRY

  • Director
0 2010-05-13 0

FRANK DANIEL

  • Director
0 2010-05-13 0

STACK DAVID M

  • Director
0 2010-05-13 0

STERLING LIONEL N

  • Director
0 2010-05-13 0

LIMBER JOSEPH M

  • Director
0 2010-05-13 0

GOTTLIEB SCOTT

  • Director
0 2010-05-13 0

WALLROTH DONALD E.

  • FORMER CHIEF FINANCIAL OFFICER
No longer subject to file 2009-12-31 0

ABDALIAN CHARLES H JR VP OF FINANCE AND CFO

  • Officer
0 2009-11-17 0

BABICH JOHN W EXEC. VP, CSO AND PRES. OF R&D

  • Officer
  • Director
0 2009-08-11 0

PETERS DANIEL PRESIDENT AND CEO

  • Officer
  • Director
0 2009-08-11 0

LAFRANCE NORMAN D. SR. VP CLINICAL DEV AND CMO

  • Officer
16,657 2009-05-28 0

WACHHOLZ JAMES VP & CHIEF REGULATORY OFFICER

  • Officer
0 2009-05-12 0

KRONAUGE JAMES F VP PROCESS CHEMISTRY

  • Officer
0 2009-05-12 0

BARRETT JOHN A V.P. OF PRECLINICAL DEV.

  • Officer
0 2009-05-12 0

LOONEY PAUL ANTHONY CHIEF OPERATING OFFICER

  • Officer
0 2009-05-12 0

EPSTEIN DAVID R

  • Director
0 2008-09-22 0

GREENSTREET YVONNE

  • Director
0 2008-09-22 0

MARTIN ANTHONY FRANCIS

  • Director
0 2008-09-22 0

HAMERMESH JOSHUA VP COMM & BUS DEVELOPMENT

  • Officer
0 2008-06-18 0

HARLAN PRISCILLA VP CORPORATE COMMUNICATIONS

  • Officer
0 2008-06-18 0

MCCRAY JOHN E CHIEF OPERATING OFFICER

  • Officer
220,304 2008-05-20 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments